The FDA has accepted a new drug application for the intravesical solution of UGN-102 in low-grade intermediate-risk non–muscle-invasive bladder cancer. A new drug application (NDA) has been accepted ...
New hope could be on the horizon for ALS patients in the form of a "breakthrough" drug ... This month, Neuvivo submitted a new drug application (NDA) to the U.S. Food and Drug Administration ...
has accepted the New Drug Application (NDA) for TLX101-CDx (Pixclara®[1]), an agent for the imaging of glioma. The application has been granted priority review and designated a PDUFA[2] goal date ...
acceptance of the New Drug Application (NDA) for investigational drug UGN-102 (mitomycin) for intravesical solution. UGN-102 could become the first FDA-approved medicine for the treatment of low ...
Standard components of the forms include the subject name, subject study number, and the names and contact information of the authorized prescribers of the study drug. The drug name, dosage ...
A new drug for people who have one of the worst forms of multiple sclerosis aims to make treatment much easier for patients. Ocrevus is a medicine commonly used to treat primary progressive MS ...
Oct. 09, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class ... New Drug (IND) application from the U.S. Food ...
2monon MSN
Eli Lilly released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to increase ...
a University of Cincinnati researcher presented Phase 3 clinical trial results finding a new drug is a safe and effective treatment for the most severe and deadly form of epilepsy. UC's Brandon ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback